Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 132

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 132
---
 of Arakoda™ or a Change of Control, which is carried at fair value based on Level
3 inputs. The Company uses a probability-weighted expected return method to determine the fair value of the contingent milestone payment
using significant inputs such as the timing and probability of discrete potential exit scenarios, forward interest rate curves, and discount
rates based on implied and market yields. See Note 8 for more information on Derivative Liabilities.

Liabilities measured at fair value at December 31, 2024 and 2023 are
as follows:

    December 31, 2024 

    Level 1  
    Level 2  
    Level 3  
    Total 
  
    Liabilities: 

    Derivative Liabilities 
    $         -  
    $        -  
    $640,830  
    $640,830 
  
    Total 
    $-  
    $-  
    $640,830  
    $640,830 

    December 31, 2023 

    Level 1  
    Level 2  
    Level 3  
    Total 
  
    Liabilities: 

    Derivative Liabilities 
    $          -  
    $         -  
    $2,306,796  
    $2,306,796 
  
    Total 
    $-  
    $-  
    $2,306,796  
    $2,306,796 

There were no transfers of financial instruments
between Level 1, Level 2, and Level 3 during the periods presented. However, certain liabilities measured at fair value and using Level
3 inputs were extinguished during the year ended December 31, 2023. A rollforward of liabilities measured at fair value using Level 3
inputs outstanding during the years ended December 31, 2024 and 2023 are presented in Notes 7 (Debt) and 8 (Derivative Liabilities).

Assets and Liabilities Not Measured at Fair Value on a Recurring
Basis

In addition to assets and liabilities that are
measured at fair value on a recurring basis, the Company also measures certain assets and liabilities at fair value on a nonrecurring
basis. The Company’s non-financial assets, including Intangible Assets and Property and Equipment, are measured at fair value when
there is an indication of impairment and the